The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.
Study Type
OBSERVATIONAL
Enrollment
1,000
The Advanta VXT graft is a two (2)-layer graft employing a single layer ePTFE graft, which is then wrapped with an additional layer of ePTFE for increased support. Some Advanta VXT configurations include Helix, which is a monofilament bead wrapped circumferentially around a portion or the entire length of the graft (such a graft is also called a Ringed Graft). The helix rings are bonded to the exterior surface of the graft. Advanta VXT Tapers are formed by changing the graft diameter, expanding from a small Inner Diameter (ID) to a larger ID (with the result that one end is larger).
The Flixene vascular graft is a three (3)-layered graft comprised of ePTFE. The Flixene graft was designed with an additional layer of ePTFE. As a result of its design, ring support is not necessary
Massachusetts General Hospital
Boston, Massachusetts, United States
RECRUITINGCHU de Brest
Brest, Brittany Region, France
RECRUITINGPercentage of Participants meeting Primary Efficacy Endpoint
Primary patency defined as freedom from graft occlusion or reintervention
Time frame: Procedure/surgery through registry completion (a minimum of 3 years)
Percentage of Participants meeting Primary Safety Endpoint
Major Adverse Limb Events (MALE), defined as major amputation or major reintervention, including placement of a new bypass graft, interposition graft, thrombectomy, or thrombolysis
Time frame: Procedure/surgery through registry completion (a minimum of 3 years)
Incidence of Reported Complications/Events
Time frame: Procedure/surgery through registry completion (a minimum of 3 years)
Percentage of Participants meeting Primary-Assisted Graft Patency
Defined as freedom from graft occlusion irrespective of whether an intervention was performed; in other words, primary-assisted patency is not lost when a reintervention is performed to preserve graft patency before occlusion occurs
Time frame: Procedure/surgery through registry completion (a minimum of 3 years)
Percentage of Participants meeting Secondary Graft Patency
Defined as freedom from "permanent" loss of graft patency
Time frame: Procedure/surgery through registry completion (a minimum of 3 years)
Rate of change in Rutherford Category
Time frame: Baseline, procedure/surgery, through registry completion (a minimum of 3 years)
Rate of change in Ankle-Brachial Index (ABI)
Time frame: Baseline, procedure/surgery, through registry completion (a minimum of 3 years)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.